The New York Times reports:
The Biden administration, under intense pressure to address the devastating coronavirus crisis in India, intends to share up to 60 million doses of the AstraZeneca vaccine with other nations, so long as the doses clear a safety review conducted by the Food and Drug Administration, officials said Monday.
The announcement came after President Biden spoke with Prime Minister Narendra Modi of India, “committing that the United States and India will work closely together in the fight against Covid-19,” according to statement from the White House.
But the commitment is a tricky one to make: The AstraZeneca doses are manufactured at the Baltimore plant owned by Emergent BioSolutions, where production has been halted amid fears of contamination.
Read the full article.
Breaking News: The Biden administration intends to send up to 60 million doses of the AstraZeneca coronavirus vaccine to other nations, pending a safety review. https://t.co/MSDwv375dC
— The New York Times (@nytimes) April 26, 2021